Quality of Life Among Survivors of Hodgkin Lymphoma

Memorial Sloan Kettering Cancer Center (MSK)

Status: Completed

Conditions: Hodgkin's Disease

Treatments: Behavioral: Quality of Life Questionaires

Study type: Observational

Funder types: Other

Identifiers

NCT00598728

05-041

Details and patient eligibility

About

The purpose of this study is to collect information on the long-term side effects of treatment for Hodgkin Lymphoma. We hope to study about 500-800 survivors of Hodgkin Lymphoma. We plan to use the findings from this study to better understand Hodgkin Lymphoma survivors' health and quality of life.

Enrollment: 255 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Biopsy-proven HL Participation in IRB-approved protocols for the first-line treatment of HL between 1975-2000 (IRB #75-104, #75-103, #79-17, #81-103, #90-44, #91-69).
• English speaking

Exclusion criteria

• None

Trial design

255 participants in 1 patient group

1

Description:

Hodgkin lymphoma Survivors

Treatment:

Behavioral: Quality of Life Questionaires